Michael Whalen, MD
Michael Whalen, MD
Associate Pediatrician, Massachusetts General Hospital
About Michael Whalen, MD
Departments, Centers, & Programs:
Clinical Interests:
- Gene transfer
- Traumatic injuries
Treats:
- Pediatrics
Locations
Pediatric Critical Care Unit
55 Fruit Street
Boston, MA 02114-2696
Phone: 617-724-4380
Fax: 617-724-4391
Medical Education
- MD, University of Vermont College of Medicine
- Residency, Medical College Virginia Hospitals
- Fellowship, Children's Hospital of Pittsburgh
American Board Certifications
- Pediatric Critical Care Medicine, American Board of Pediatrics
Accepted Insurance Plans
- Aetna Health Inc.
- AllWays Health (NHP) - ACD
- AllWays Health (NHP) - PBO
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- BMC HealthNet Mass Health MCO/ACO
- Cigna (PAL #'s)
- Commonwealth Care Alliance
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Maine Community Health Options (MCHO)
- MassHealth
- Medicare
- Medicare - ACD
- OSW - Connecticut
- OSW - Maine
- OSW - New Hampshire
- OSW - New York
- OSW - Rhode Island
- OSW - Vermont
- Private Health Care Systems (PHCS)
- Railroad Medicare
- Railroad Medicare - ACD
- Senior Whole Health
- TriCare
- Tufts Health Plan
- Unicare
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- Well Sense Pediatrics
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
Dr. Whalen's laboratory investigates causes and treatments for acute brain injury in children with mouse models and molecular and cell biology. The laboratory studies mechanisms of concussion, brain contusion, and intracerebral hemorrhage (a type of stroke) in pediatric and adult models. We focus on how inflammation drives neurological outcome in these models in order to discover new treatments to improve neurological outcome in children and adults with brain injury.